New Delhi: Researchers at the National Institute of Technology (NIT), Rourkela, have developed a low-cost indigenous force plate for measuring multi-axial ground reaction forces (GRF) to help in gait profiling, according to officials. Force plates are …

Coverage of aging is supported in part by AARP Arizona People living with a form of Lewy body dementia potentially have access to a promising investigational drug that appears to reduce or improve symptoms. Dr. Dave Shprecher is a movement disorder …

Parkinson's disease manifests with numerous symptoms, over 40 in fact, including the well-recognised tremor in the arms and hands. The development and order of these symptoms vary amongst the roughly 153,000 UK residents living with this incurable, …

By Patricia Weiss FRANKFURT (Reuters) -Bayer’s pioneering cell and gene therapies for Parkinson’s disease are at the forefront of an exciting but risky test of CEO Bill Anderson’s development credentials as patent expiries on blockbuster drugs threaten the …

At an awareness seminar on World Alzheimer's Day in Bangalore, India, in 2024, a participant walks past. On Wednesday, University College London medical researchers announced what they say is the world's first successful treatment for Huntington…

New discovery shows that a unique nanomaterial called graphitic carbon nitride (g-C N ) has been shown to stimulate your brain cells without the need for invasive tools like electrodes, lasers or magnets. In a big scientific breakthrough Indian scientists …

Experts have shared ten little-known warning signs that someone you love—or yourself—is developing Parkinson's disease, the progressive neurological disorder which took Ozzy Osbourne's life. It is estimated in the UK that someone is diagnosed with …

INST scientists develop nanomaterial capable of naturally communicating with neurons.Scientists from the Institute of Nano Science and Technology (INST), an autonomous institute of the Department of Science and Technology (DST), have developed a special …

STOCKHOLM, Sept. 24, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi) for the treatment of adult patients with …

BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned, independently operated subsidiary of Bayer AG, announced that the first patient has received randomized treatment in the pivotal phase III clinical trial, exPDite-2, of …